Nanox Flags Going-Concern Doubt as Cash Falls to $26M; Q3 Revenue $4.3-4.4M
NNOX is trading near its 52-week low of $0.446 (3.4% above the low).
Summary
Nanox reported preliminary Q3 revenue of $4.3-$4.4 million, up from $3.4 million a year ago, but disclosed that its $26.0 million of cash and deposits is not enough to fund operations for at least one year — a going-concern warning that puts the focus squarely on raising capital.
Key Events · Earnings and Guidance · NNOX
-
Going-Concern Warning Disclosed
Management states cash, cash equivalents and deposits of approximately $26.0 million as of September 30, 2026 are not sufficient to support operations for at least one year, raising substantial doubt about the ability to continue as a going concern.
-
Cash Burned Down to $26.0M
Cash, cash equivalents, short-term deposits and long-term restricted deposits fell to approximately $26.0 million at September 30, 2026 from $60.0 million at December 31, 2025 — roughly $34 million consumed in nine months.
-
Preliminary Q3 Revenue $4.3-4.4M
Revenue for the three months ended September 30, 2026 is estimated at $4.3-$4.4 million versus $3.4 million a year earlier; AI and software solutions contributed $1.0 million (up from $0.1 million) on the Vaso Healthcare IT consolidation, teleradiology was flat at about $3.1 million, and imaging systems/OEM contributed about $0.3 million.
-
Nasdaq Delisting Notice Overhang
The company received a Nasdaq delisting notice on October 2, 2026 after its shares traded below $1.00 for 30 consecutive days, and it must regain compliance or face delisting.
Analysis · NNOX · Industrial Applications And Services
The dominant fact is an explicit going-concern warning: cash and deposits fell to roughly $26.0 million at September 30 from $60.0 million at year-end, and management states these funds are not sufficient to support operations for at least one year. That means the company must raise capital, and it already has a $100M shelf, a $53.9M ATM capacity that requires shareholder approval to use fully, and a Nasdaq delisting notice from October 2 after shares traded below $1.00 for 30 consecutive days. Revenue is improving — preliminary Q3 revenue of $4.3-$4.4 million versus $3.4 million a year ago, with AI and software revenue jumping to $1.0 million from $0.1 million on the Vaso Healthcare IT consolidation — but the operating cash burn dwarfs that growth. The business update (Nanox.AI distribution deal in Italy, TIME Best Inventions recognition for Nanox.ARC X) is incremental and does not change the funding picture.
How filings like this one have moved
In the 30 days to Oct 16, 2026, 45.2% of the 299 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.26%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, NNOX was trading at $0.46 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $35.6M. The 52-week trading range was $0.45 to $4.71. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.